Blepharitis Market Research, Consumption Analysis, Business Overview and Upcoming Trends 2030
Involvement of Leading Players Projected to
Influence a Positive Growth to the Global Blepharitis Market
Blepharitis
is a common condition of ophthalmologic disorder. The disorder causes
inflammation of the eyelids, which leads to irritation in the eyes. It is
caused by either bacteria or skin related conditions like dandruff or oil
overproduction from the glands of the eyelids. The global blepharitis
market Research is projected to attain a CAGR of 6.5% during the assessment
period.
The market
is primarily driven by the surging prevalence of ophthalmological ailments like
uveitis, dry eye, and others. Other factors influencing a positive demand on
the market are rising demand for advanced form of treatments, favorable
government initiatives, emergence of market players offering various new
products for blepharitis treatment, and increasing awareness concerning eye
care are all expected to likely drive the blepharitis market. Additionally, the
involvement of various important players in upgrading their existing products
and development of new products is also believed to boost the global
blepharitis market.
Market Segmentation
The global
blepharitis market segmentation is done in the following basis: end-user,
treatment, type, and diagnosis.
By type,
the market includes posterior blepharitis, anterior blepharitis, and mixed
blepharitis.
By
end-users, the market comprises of hospitals, specialty centers, and others.
By
treatment, the market is antibiotic therapy, eye cleansers, and artificial
tears. The antibiotic therapy segment is narrowed down into oral antibiotic
therapy and topical antibiotic therapy.
By
diagnosis, the market is classified into comprehensive eye examination, physical
examination, and others.
Regional Analysis
The
geographical segmentation of the global blepharitis market covers the Americas,
Europe, Asia Pacific, and the Middle East & Africa region.
North
America is the market leader in blepharitis in the global standings. The
Americas region is segmented into two contributors, namely South and North
America. In North America, the maximum percentage of the contribution is
attributed to the US and Canada. Here, increasing prevalence of eye disorders
coupled with the growing awareness among the consumers concerning the need for
proper eye care is likely to push the market growth. Add to this, the
increasing involvement of various leading players in the market, rising support
from the government, and the growing expenditure in the healthcare sector are
some of the other factors that are likely to enhance the blepharitis market.
Standing
tall with the second largest market share, Europe holds a healthy presence in
the global blepharitis market. The market in this region is anticipated to
witness decent growth during the forecast period due to various reasons. This
includes, the presence of a large pool of market players that are offering
effective and innovative products, rising number of skilled medical professionals,
and a surging demand for improved and advanced healthcare infrastructure.
Asia
Pacific region is said to be potentially the fastest growing market in the
globe. Herein, rising prevalence of eye-related disorders and growing patient
population are slated to be the major market drivers.
The Middle
East and African region is expected to experience the least growth percentage
due to significant market constraints like lack of awareness concerning the
disease and limited treatment facilities. However, the United Arab Emirates
(UAE) region is the largest market share holder under the MEA region due to
continuous development of the healthcare sector and growing demand for various
advanced specialty centers.
Competitive Landscape
Some of the
leading players in the global blepharitis market are Scope Ophthalmics Ltd,
NovaBay Pharmaceuticals, Inc., Merck & Co., InSite Vision Incorporated,
Galderma S.A., Perrigo Laboratories, Thea Pharmaceuticals Limited, and Novartis
AG.
March 14th,
2019, Bruder announced in a press release about the launch of its two dry eye
products, named Eyeleve Contact Lens Compress and Bruder Hygienic Eyelid
Solution. The solutions are said to be safe and secure for daily and long-term
use for patients suffering with conditions such as meibomian glan dysfunction
and blepharitis.
March 7th,
2019, it was announced by Sight Science at SECO 2019 that they might be
launching their new technology for applying heat to the eyelids this May. The
product is named as TearCare.
About US:
Market Research Future (MRFR) enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment